Clinical Trial

Small Nerve Fiber Activity in Patients with Carpal Tunnel Syndrome Assessed Via Quantitative Sensory Testing

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 5, 2025 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.
Summary
The diagnosis of carpal tunnel syndrome (CTS) is typically based on clinical findings and confirmatory electrodiagnostic testing. However, electrodiagnostic testing can only assess large A-alpha and A-beta nerve fibers. Quantitative sensory testing (QST) is a series of tests used to assess small nerve fiber changes in the A-delta, c-fibers, and A-beta nerve fibers as well. Previous studies have used QST to assess small nerve fiber changes related to carpal tunnel syndrome and found changes compared to controls. This study will utilize a course of standard physical therapy care and assess for any changes to small nerve fiber activity and how those changes may or may not relate to patient outcomes.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-08-09.
Status change: Not Yet Recruiting → Recruiting 2025-02-03
Trial Details
NCT Number NCT06550284
Lead Sponsor Brooke Army Medical Center
Conditions Carpal Tunnel Syndrome
Enrollment 48 participants
Start Date 2024-11-12
Primary Completion 2025-07 (estimated)
Study Completion 2025-07 (estimated)
Updated on ClinicalTrials.gov 2025-02-05